Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $1.35 (-1.46%), Market cap $0.04B, 52-week low–high $0.71 ~ $12.66.
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zheng
Financial statements, price targets, institutional (13F) holdings and related news for Zhengye Biotechnology Holding Limited Ordinary Shares are updated in real time on BlackAll Trade.
Zhengye Biotechnology Holding Limited Ordinary Shares trades at $1.35 (-1.46%). Real-time quotes and charts are available on BlackAll Trade.
Zhengye Biotechnology Holding Limited Ordinary Shares has a market cap of about $0.04B.
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, s